Dupixent Approved for Chronic Rhinosinusitis With Nasal Polyps

WEDNESDAY, June 26, 2019 -- Dupixent (dupilumab) has been approved to treat nasal polyps in adults with chronic rhinosinusitis, the U.S. Food and Drug Administration announced today. Dupixent, which is administered through injection, was previously...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news